Helping Women 75 and Older Decide About Screening Mammography

In a randomized trial, a decision aid reduced screening mammography among older women.

Unlike screening mammography in younger women, such screening does not appear to reduce breast cancer mortality in women aged ≥75 (NEJM JW Womens Health Feb 2020 and Ann Intern Med 2020 Feb 25 [e-pub]); moreover, U.S. Preventive Services Task Force guidance states that current evidence is insufficient to assess benefits and harms of screening in women aged ≥75 (NEJM JW Womens Health Feb 2016 and Ann Intern Med 2016 Jan 12 [e-pub]). Investigators developed a decision aid (DA) tailored to women aged ≥75 that accounts for breast cancer risk factors, competing mortality risks, and screening outcomes. In a cluster randomized trial, women aged 75–89 who were scheduled for a routine visit with their primary care provider (PCP) and who had been scr…

Reviewing Author

Andrew M. Kaunitz, MD

Disclosures

RoyaltiesUpToDate

Grant/Research SupportMerck, Mithra, Medicines360

Editorial BoardsContraception; Menopause; Contraceptive Technology Update; OBG Management; Medscape OB/GYN & Women’s Health

Andrew M. Kaunitz, MD

Disclosures

RoyaltiesUpToDate

Grant/Research SupportMerck, Mithra, Medicines360

Editorial BoardsContraception; Menopause; Contraceptive Technology Update; OBG Management; Medscape OB/GYN & Women’s Health

Helping Women 75 and Older Decide About Screening Mammography

Topics

Reviewing Author